|
|||||
|
|
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters |
|
| Authors: | Franklin A. Valdera Anne E. O'Shea Todd R. Smolinsky Elizabeth L. Carpenter Alexandra A. Adams Patrick M. McCarthy Ankur Tiwari Robert C. Chick Phillip M. Kemp-Bohan Spencer Van Decar Katryna K. Thomas Julia O. Bader George E. Peoples Guy T. Clifton Alex Stojadinovic Daniel W. Nelson Timothy J. Vreeland |
| Affiliation: | 1. Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA;2. Department of Surgery, University of Texas San Antonio Health Science Center, San Antonio, Texas, USA;3. Cancer Insight, LLC, San Antonio, Texas, USA;4. Department of Surgery, William Beaumont Army Medical Center, El Paso, Texas, USA |
| Abstract: | |
| Keywords: | chemotherapy neoadjuvant pancreatic adenocarcinoma |